MedTrace Logo

Short-term Effectiveness of Transcutaneous Nerve Stimulation in Reducing Migraine Related Pain

NCT02438553 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-01-07

No results posted yet for this study

Summary

The purpose of this study is to evaluate the short-term effectiveness of combined occipital and supraorbital transcutaneous nerve stimulation in reducing migraine related pain.

Conditions

  • Headache, Migraine

Interventions

DEVICE

OSTNS Neurostimulator

Non-invasive transcutaneous neurostimulation.

DEVICE

Placebo OSTNS Neurostimulator

Placebo non-invasive transcutaneous neurostimulation

Sponsors & Collaborators

  • Neurolief Ltd.

    lead INDUSTRY

Principal Investigators

  • Rachel Hering, Dr. · Director of headache clinic, Department of Neurology, Meir General Hospital, Kfar Saba, Israel.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02438553 on ClinicalTrials.gov